Medios Technologies

Software development company creating deep learning software to assist doctors in grading fundus images for detection of diabetic retinopathy, a type of blindness causes by disease related changes in the vasculature of the retina.

All edits

Article

The technology uses an AI assistant to help any physician detect diabetic retinopathydiabetic retinopathy in the absence of a specialist with the goal of early detection for preventing blindness.Screening for diabetic retinopathy before symptoms occur, can prevent blindness.

Diagnostic Accuracy of Community-Based Diabetic Retinopathy Screening With an Offline Artificial Intelligence System on a Smartphone. - PubMed - NCBI

Article

MEDIOS-AI is an AI integrated retinal imaging device that uses the Remidio smartphone. TheA study of the feasibility of using this smartphone-based retinal camera with in-built offline artificial intelligence algorithm to screen for diabetic retinopathy has beenwas published in 2019 JAMA Opthalmology. More than 1300 patients with diabetes mellitus were screened by a team from Aditya Jyot Foundation for Twinling Little Eyes, Mumbae, led by Dr. Natarajan, who is President of the All India Opthalmology Society. Diagnostic accuracy of MEDIOS-AI to detect referable diabetic retinopathy was validated. The AI provides a report in less than 10 seconds. The platform could be extended to other sight-threatening chronic diseases such as glaucoma.

Article

The technology uses an AI assistant to help any physician detect diabetic retinopathy in the absence of a specialist with the goal of early detection for preventing blindness.Screening for diabetic retinopathy before symptoms occur, can prevent blindness.

...

MEDIOS-AI is an AI integrated retinal imaging device that uses the Remidio smartphone. The feasibility of using this smartphone-based retinal camera with in-built offline artificial intelligence algorithm to screen for diabetic retinopathy has been published in JAMA Opthalmology. More than 1300 patients with diabetes mellitus were screened by a team from Aditya Jyot Foundation for Twinling Little Eyes, Mumbae, led by Dr. Natarajan, who is President of the All India Opthalmology Society. Diagnostic accuracy of MEDIOS-AI to detect referable diabetic retinopathy was validated. The AI provides a report in less than 10 seconds. The platform could be extended to other sight-threatening chronic diseases such as glaucoma.

Article

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, SingaporeSingapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de Lausanne, Switzerland. India is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

Article

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, Singapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de Lausanne, Switzerland. IndiaIndia is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

Article

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, Singapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de LausanneLausanne, Switzerland. India is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

Article

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, Singapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de Lausanne, SwitzerlandSwitzerland. India is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

Medios Technologies

Software development company creating deep learning software to assist doctors in grading fundus images for detection of diabetic retinopathy, a type of blindness causes by disease related changes in the vasculature of the retina.

Article

The technology uses an AI assistant to help any physician detect diabetic retinopathy in the absence of a specialist with the goal of early detection for preventing blindness.

...

Co-founder Bhargav Sosale is a software engineer and product designer who graduated from Nanyang Technological University, Singapore and whose father, mother and sister are diabetes doctors. Co-founder Florian Savoy is an expert in computer vision with research experience at University of Illinois and a degree from École polytechnique fédérale de Lausanne, Switzerland. India is planned to be the company’s first market and the diagnosis will cost $1. Medios is partnered with retinal camera companies including Remidio and Intuvision.

Categories

Medios Technologies

Software development company creating deep learning software to assist doctors in grading fundus images for detection of diabetic retinopathy, a type of blindness causes by disease related changes in the vasculature of the retina.